Mandate

Vinge advised SAS in alleged discrimination claim

March 26, 2013

Vinge has advised SAS in its successful defence in proceedings at Stockholm District Court where Swedish SAS pilots had pursued an action in damages against SAS for alleged breaches of EU law.

The 33 SAS pilots were previously employed by Linjeflyg and commenced proceedings against SAS for alleged breaches of EU law in connection with their employment by SAS following the winding up of Linjeflyg in 1992. In brief, the claimants alleged that SAS had acted unlawfully by failing to permit them to include the period of service with their previous employer and as a consequence thereof had discriminated against them due to their Swedish nationality and thereby preventing them from exercising their freedom of movement under EU law.

The Court dismissed the claimant’s claims in a judgment delivered on 22 March this year. In its judgment, the Court states that EU law is not applicable to the pilots’ employment agreements since the circumstances pertained to purely internal, Swedish circumstances. The Court also notes that even if EU law had been applicable, the pilots’ claims could not succeed. The terms of employment did not entail that the pilots were discriminated against on the ground of their nationality or that they were prevented from exercising their right of free movement. Rather, the pilots had in fact received more favourable treatment compared to other newly-employed SAS pilots. In addition, the terms of employment were not contrary to generally accepted practice on the labour market or otherwise incompatible with Swedish labour law.  

The pilots now have three weeks in which to appeal the District Court’s judgment to the Swedish Labour Court. The Labour Court must also grant permission to appeal.

Vinge’s team consisted of Fredrik Gustafsson, Martin Johansson and Björn Lindskog.

Related

Vinge has advised Vimian Group AB in connection with its uplisting to Nasdaq Stockholm

Vinge has advised Vimian Group AB (publ) in connection with its list change from Nasdaq First North Growth Market to Nasdaq Stockholm’s main market, Large cap. The prospectus was published on 21 March 2025 and the trading on Nasdaq Stockholm commenced on 28 March 2025.
March 28, 2025

Vinge advises Tribune Therapeutics in conjunction with financing round

Vinge advises Tribune Therapeutics, a Swedish biotechnology company focused on developing therapies for fibrotic diseases, in raising 23 MEUR. The financing round includes the previous investors HealthCap, Novo Holding and Innovestor, in addition to the new investors LifeArc Ventures, Industrifonden and Investinor.
March 26, 2025

Vinge advises Dignitana on the public offer from Paxman

Paxman AB (publ) has announced a public offer to the shareholders of Dignitana AB. The total value of the offer is approximately SEK 153 million.
March 24, 2025